This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Email this article to a friend
Tumor metastasis to bone
-
* Corresponding author: Jay R Lieberman jlieberman@uchc.edu
Arthritis Research & Therapy 2007, 9(Suppl 1):S5 doi:10.1186/ar2169